Home » Topics » Regulatory

Regulatory
RSS

Recombinant hGH approved in E.U. for Turner's syndrome

Jan. 24, 2001

Cangene's chickenpox vaccine approved in Canada

Jan. 23, 2001

Oral formulation of Fludara now available in U.K.

Jan. 23, 2001

Schering-Plough submits two new applications for desloratadine in the E.U.

Jan. 22, 2001

Use of rhIL-11 for the treatment of hemorrhagic shock described by Genetics Institute

Jan. 19, 2001

Novel combination therapies useful for weight gain associated with antipsychotic drugs

Jan. 19, 2001

Combinations of lipopeptides and other antifungal agents reported to be synergistic

Jan. 19, 2001

Tacrolimus claimed for conditions associated with cartilage damage

Jan. 18, 2001

Schering-Plough's Aerius/NeoClarityn approved in E.U. for treatment of seasonal allergic rhinitis

Jan. 18, 2001

Continuous combined HRT with Climodien cleared for marketing in The Netherlands

Jan. 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...